We studied the association between the increased levels of STAT3 activation and high-grade ovarian carcinomas, consistent with a role for STAT3 in the motile phenotype of ovarian cancer cells in response to direct activation by EGFR or indirectly through IL-6R. The gene discussed is EGFR; the disease is ovarian cancer.